Processa Pharmaceuticals, Inc.
PCSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533743
In the last 90 days, Processa Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $498.3K in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Processa Pharmaceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- −7 vs. Q4 2023
- Shares held
- 106.3K
- −1.02M (−90.6%) vs. Q4 2023
- Total value
- $251.5K
- −$125.0K (−33.2%) vs. Q4 2023
- New holders
- 4
- 2 more added
- Sold out
- 11
- 5 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PCSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $498.3K |
| Q1 2026 | 10 | $448.5K |
| Q4 2025 | 10 | $331.0K |
| Q3 2025 | 14 | $341.9K |
| Q2 2025 | 13 | $75.9K |
| Q1 2025 | 9 | $63.2K |
| Q4 2024 | 8 | $87.5K |
| Q3 2024 | 8 | $66.5K |
| Q2 2024 | 9 | $101.0K |
| Q1 2024 | 11 | $251.5K |
| Q4 2023 | 18 | $376.5K |
| Q3 2023 | 20 | $349.8K |
| Q2 2023 | 19 | $691.4K |
| Q1 2023 | 22 | $852.6K |
| Q4 2022 | 18 | $1.28M |
| Q3 2022 | 18 | $2.58M |
| Q2 2022 | 18 | $3.24M |
| Q1 2022 | 18 | $3.22M |
| Q4 2021 | 19 | $6.47M |
| Q3 2021 | 18 | $12.2M |
| Q2 2021 | 18 | $11.2M |
| Q1 2021 | 17 | $12.3M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Processa Pharmaceuticals, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sabby Management, LLC | 48,601 | $114.9K | 0.75% | +48,601 | New |
| Vanguard Group Inc | 24,433 | $57.8K | 0.00% | −210,220−89.6% | Reduced |
| Two Sigma Investments, LP | 24,096 | $57.0K | 0.00% | +5,419+29.0% | Added |
| Tower Research Capital LLC (TRC) | 4,505 | $10.7K | 0.00% | +3,310+277.0% | Added |
| UBS Group AG | 4,181 | $9.89K | 0.00% | −75,842−94.8% | Reduced |
| Wells Fargo & Company | 170 | $402 | 0.00% | −3,077−94.8% | Reduced |
| Bank of America Corp | 160 | $378 | 0.00% | +160 | New |
| Main Street Group, LTD | 100 | $235 | 0.00% | +100 | New |
| Allworth Financial LP | 85 | $202 | 0.00% | −1,615−95.0% | Reduced |
| Macroview Investment Management LLC | 1 | $3 | 0.00% | +1 | New |
| Royal Bank of Canada | 4 | $0 | 0.00% | −46,302−100.0% | Reduced |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −315,410−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −122,033−100.0% | Sold out |
| Spinnaker Trust | 0 | $0 | 0.00% | −76,865−100.0% | Sold out |
| Coastal Bridge Advisors, LLC | 0 | $0 | 0.00% | −64,956−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −58,200−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −42,786−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −28,139−100.0% | Sold out |
| McCollum Christoferson Group LLC | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Courier Capital LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,717−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −293−100.0% | Sold out |